TrialBlood2022

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.

Muzaffar H Qazilbash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.